Review

Use of Bevacizumab in the Treatment of Corneal Neovascularization

• Tuba Çelik
• Mustafa Köşker

Diabetic Macular Edema and its Treatment Modalities

• Raciha Beril Küçümen
• Nursal Melda Yenerel

Uveitis in 2010: Advances in the Diagnosis, Follow-up, and Treatment

• İlknur Tugal Tutkun
• Carl P. Herbort

Original Article

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection

• Mahmut Kaya
• Ferit Hakan Öner
• Betül Akbulut Yağcı
• Ferdane Ataş
• Taylan Öztürk

Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration

• Remzi Avcı
• Ayşegül Mavi Yıldız
• Esat Çınar
• Sami Yılmaz
• Cem Küçükerdönmez
• Fatma Duriye Akalp
• Emre Avcı

The Effect of Intravitreal Bevacizumab on Apoptosis of Rat Retina Cells

• Özcan Kayıkçıoğlu
• Seda Vatansever
• İsmet Topçu
• Işıl Aydemir
• Tuğçe Bilecenoğlu
• Fatih Kahvecioğlu
• Sinan Emre

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

• Müge Çoban Karataş
• Gürsel Yılmaz
• Aslıhan Yüce Sezen
• Çağla Sarıtürk

The Levels of VEGF and IL-8 in Vitreous Samples From Patients with Proliferative Vitreoretinopathy due to Rhegmatogenous Retinal Detachment

• Rıfat Rasier
• Halil Özgür Artunay
• Erdal Yüzbaşıoğlu
• Alper Şengül
• Uzay Görmüş
• Murat Öncel
• Halil Bahçecioğlu

The Preventive Effect of Oxytocin on Retinopathy in Streptozotocin- Induced Diabetic Rats

• Cumali Değirmenci
• Filiz Afrashi
• Oytun Erbaş
• Hüseyin Aktuğ
• Dilek Taşkıran

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy

• Serhad Nalçacı
• Cezmi Akkın
• Filiz Afrashi

Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration

• Pelin Kıyat
• Jale Menteş
• Serhad Nalçacı
• Filiz Afrashi
• Mine Barış

Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy

• Seher Eraslan
• Özlem Yıldırım
• Özer Dursun
• Erdem Dinç
• Gülhan Orekici Temel

Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association

• V. Levent Karabaş
• Ecem Önder Tokuç
• Figen Şermet

The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture

• Mustafa Şahiner
• Dilek Bahar
• Ayşe Öner
• Zeynep Burçin Gönen
• Metin Ünlü
• Duygu Gülmez Sevim
• Çağatay Karaca
• Galip Ertuğrul Mirza

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1

• Abdullah Özkaya
• Levent Karabaş
• Cengiz Alagöz
• Zeynep Alkın
• Özgür Artunay
• Selim Bölükbaşı
• Gökhan Demir
• Mehmet Demir
• Ali Demircan
• Burak Erden
• Gürkan Erdoğan
• Mehmet Erdoğan
• Erdem Eriş
• Havva Kaldırım
• İsmail Umut Onur
• Özen Osmanbaşoğlu
• Sezin Özdoğan Erkul
• Mine Öztürk
• İrfan Perente
• Kübra Sarıcı
• Nihat Sayın
• Dilek Yaşa
• İhsan Yılmaz
• Zeynep Yılmazabdurrahmanoğlu

Application of Topical/Subconjunctival Bevacizumab and Topical Fluorometholone Acetate in Alkali Burn-induced Model of Corneal Angiogenesis

• Ayşen Topalkara
• Mustafa İlker Toker
• Feyza Dursun
• Ayşe Vural Özeç
• Mustafa Kemal Arıcı
• Ayhan Dursun

Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment

• Jale Menteş
• Mine Esen Barış

Comparison of Efficacy Between anti-VEGF Agents Alone and in Combination with Photodynamic Therapy in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

• Sunay Duman
• Damla Ergintürk Acar
• Güner Üney
• Dicle Hazırolan
• Mehmet Akif Acar
• Nurten Ünlü

Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

• Uğur Yayla
• Mehmet Orkun Sevik
• Veysel Levent Karabaş
• Özlem Şahin
• Abdullah Özkaya
• Nursal Melda Yenerel
• Banu Açıkalın Öncel
• Fatih Bilgehan Kaplan
• Ecem Önder Tokuç
• Hatice Selen Kanar
• Işıl Kutlutürk Karagöz
• Ece Başaran Emengen
• Ayşe Demirciler Sönmez
• Aslan Aykut
• Utku Limon
• Erdinç Bozkurt
• Işılay Özsoy Saygın
• Tuğba Aydoğan Gezginaslan
• Özlem Aydın Öncü
• Esra Türkseven Kumral
• Nimet Yeşim Erçalık
• Erkan Çelik

Survey of Intravitreal Injection Techniques and Treatment Protocols Among Members of the Turkish Ophthalmological Association

• Ecem Önder Tokuç
• V. Levent Karabaş
• Figen Şermet

Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growt Factor in Ethiopathogenesis of Retinopathy of Prematurity

• Özlem Yenice
• Ahmed Ashour
• Eren Çerman
• Rıdvan Fırat
• Goncagül Haklar
• Önder Şirikçi
• İpek Akman
• Haluk Kazokoğlu

Review

Is There a Relationship Between Use of Anti-Vascular Endothelial Growth Factor Agents and Atrophic Changes in Age-Related Macular Degeneration Patients?

• Süleyman Kaynak
• Mahmut Kaya
• Derya Kaya

Case Report

Treatment Approach to Autosomal Recessive Dystrophic Epidermolysis Bullosa

• Rana Altan Yaycıoğlu
• Yonca Aydın Akova
• Fatma Selin Kaya
• Sibel Oto

Research Article

Serum Levels of VEGF and NO in Patients with Diabetic Retinopathy

• Ümit Übeyt İnan
• Mustafa Serteser
• Sıtkı Samet Ermiş
• Serap Demir
• Tülay Köken
• Faruk Öztürk